Literature DB >> 3740943

Time-dependent suppression of melanoma metastases and natural killer cell activation by interferon.

M Ueda, Y Mishima, M Mojamdar, M Ichihashi, M Kita, T Kishida.   

Abstract

The effect of murine alpha/beta interferon (IFN) on experimental metastasis was investigated using B16-F10 melanoma cells. Since the outcome of metastasis of blood-borne tumor cells is mainly determined within the first 24 h after i.v. inoculation of tumor cells, i.p. injection of IFN was focused on this critical early phase. The inhibition of pulmonary metastases by IFN was found to be maximal when given 3 h prior to tumor cell inoculation, while mice with 24-h and 12-h pretreatment and simultaneous IFN treatment also showed a reduction in metastases, but to a lesser extent. However, mice receiving IFN 2 h after tumor cell inoculation did not show any reduction. Tumor cells cultured for 24 h in IFN-containing medium showed no reduction in metastases. Administration of anti-asialo GMl prior to IFN treatment was found to eliminate the inhibitory effect of IFN 3 h pretreatment. However, natural killer (NK) cell activity in vitro measured at 3 h, 13 h and 24 h after IFN administration was enhanced to the same extent, not paralleling the inhibitory effect on pulmonary metastases. These data indicate that prepared host status against blood-borne tumor cells is established by IFN pretreatment, being maximal when injected several hours prior to tumor cell inoculation, and that this effect is substantially dependent on NK cell activity, though the implication of other factors is not excluded.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3740943     DOI: 10.1007/bf00407748

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  22 in total

1.  Functional and morphologic characteristics of interferon-treated macrophages.

Authors:  R M Schultz; M A Chirigos; U I Heine
Journal:  Cell Immunol       Date:  1978-01       Impact factor: 4.868

2.  In vivo effects of anti-asialo GM1. I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice.

Authors:  S Habu; H Fukui; K Shimamura; M Kasai; Y Nagai; K Okumura; N Tamaoki
Journal:  J Immunol       Date:  1981-07       Impact factor: 5.422

Review 3.  The pathogenesis of cancer metastasis.

Authors:  G Poste; I J Fidler
Journal:  Nature       Date:  1980-01-10       Impact factor: 49.962

4.  Motility and adhesive properties of high- and low-metastatic murine neoplastic cells.

Authors:  T Volk; B Geiger; A Raz
Journal:  Cancer Res       Date:  1984-02       Impact factor: 12.701

5.  Arrest and metastasis of blood-borne tumor cells are modified by fusion of plasma membrane vesicles from highly metastatic cells.

Authors:  G Poste; G L Nicolson
Journal:  Proc Natl Acad Sci U S A       Date:  1980-01       Impact factor: 11.205

6.  Elimination of polynucleotide-induced hyporeactivity in mice treated with interferon and antitumor therapy.

Authors:  J Imanishi; M Kita; S Sugino; T Oku; T Kishida
Journal:  J Interferon Res       Date:  1982

7.  Inhibition of experimental tumor metastasis by selective activation of natural killer cells.

Authors:  N Hanna
Journal:  Cancer Res       Date:  1982-04       Impact factor: 12.701

8.  Importance of treatment regimen of interferon as an antitumor agent.

Authors:  S H Lee; H Chiu; E Rinderknecht; W Sabo; N Stebbing
Journal:  Cancer Res       Date:  1983-09       Impact factor: 12.701

9.  Role of natural killer cells in the destruction of circulating tumor emboli.

Authors:  N Hanna; I J Fidler
Journal:  J Natl Cancer Inst       Date:  1980-10       Impact factor: 13.506

10.  Loss of melanogenic properties in tyrosinases induced by glucosylation inhibitors within malignant melanoma cells.

Authors:  G Imokawa; Y Mishima
Journal:  Cancer Res       Date:  1982-05       Impact factor: 12.701

View more
  1 in total

1.  The antitumor effects of IFN-alpha are abrogated in a STAT1-deficient mouse.

Authors:  Gregory B Lesinski; Mirela Anghelina; Jason Zimmerer; Timothy Bakalakos; Brian Badgwell; Robin Parihar; Yan Hu; Brian Becknell; Gerard Abood; Abhik Ray Chaudhury; Cynthia Magro; Joan Durbin; William E Carson
Journal:  J Clin Invest       Date:  2003-07       Impact factor: 14.808

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.